Published in
American Association for the Advancement of Science, Science Translational Medicine, 441(10), 2018
DOI: 10.1126/scitranslmed.aao4680
Links
Tools
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma
Journal article published in 2018 by
Timothy L. Lochmann 
,
Krista M. Powell,
Jungoh Ham,
Konstantinos V. Floros ,
Daniel A. R. Heisey ,
Richard I. J. Kurupi,
Marissa L. Calbert ,
Maninderjit S. Ghotra,
Patricia Greninger,
Mikhail Dozmorov ,
Madhu Gowda,
Andrew J. Souers,
C. Patrick Reynolds ,
Cyril H. Benes ,
Anthony C. Faber
,
Krista M. Powell,
Jungoh Ham,
Konstantinos V. Floros ,
Daniel A. R. Heisey ,
Richard I. J. Kurupi,
Marissa L. Calbert ,
Maninderjit S. Ghotra,
Patricia Greninger,
Mikhail Dozmorov ,
Madhu Gowda,
Andrew J. Souers,
C. Patrick Reynolds ,
Cyril H. Benes ,
Anthony C. Faber
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
High-throughput screening identified hypersensitivity of neuroblastomas to H3K27 demethylation inhibition.